Pfiz­er brings Ibrance to new sub­set of breast can­cer pa­tients, re­gard­less of menopausal sta­tus

3 years ago
Pharma
FDA+

Prothena un­veils healthy vol­un­teer safe­ty da­ta for Alzheimer's drug in Bris­tol My­ers col­lab

3 years ago
R&D

KKR health­care vet Jim Mom­tazee’s in­vest­ment firm clos­es $3.9B in­au­gur­al fund

3 years ago
People
Financing

Sim­ba Gill stay­ing on at Evelo to weath­er lay­offs and a PhII fail

3 years ago
People
R&D

Green­Light's mR­NA vac­cine nabs tri­al OK; Ra­tio reels in ra­dio­ther­a­py funds

3 years ago
Financing
News Briefing

'Moon­shot' at liv­er cell ther­a­py biotech Am­bys Med­i­cines comes to an end

3 years ago
People
Startups

GSK drops celi­ac drug, an­ti-bac­te­r­i­al vac­cine in lat­est pipeline sweep

3 years ago
R&D

2022 was about ex­e­cu­tion. Now will Am­gen's growth strat­e­gy prove its worth?

3 years ago
Pharma

Up­dat­ed: No­var­tis re­jigs late-stage plans for Cosen­tyx, next-gen CAR-T, TIG­IT an­ti­body and more

3 years ago
R&D

Cell ther­a­py biotech shifts fo­cus to UK, makes deep cuts to US head­count

3 years ago
People
R&D

New com­peti­tors push Sanofi to of­fer vol­un­tary re­tire­ment pack­ages at two In­di­an sites

3 years ago
People
Pharma

Pfiz­er's Al­bert Bourla spells out 'tran­si­tion year' for Covid prod­ucts, with sales ex­pect­ed to reach a low point

3 years ago
Pharma

Pfiz­er scores high­est spend­ing dur­ing NFL sea­son among phar­ma ad­ver­tis­ers — iS­pot analy­sis

3 years ago
Pharma
Marketing

Amid ap­pli­ca­tion tsuna­mi, FDA's top cell and gene ther­a­py leader to re­tire in March

3 years ago
People
FDA+

Pan­dem­ic wait is over: FDA be­gins tran­si­tion to in-per­son meet­ings in March

3 years ago
FDA+

Covid pub­lic health emer­gen­cies to end in May, but FDA's EUA au­thor­i­ty will con­tin­ue

3 years ago
Pharma
FDA+

Mar­ket­ingRx roundup: Pub­li­cis takes can­cer work­place ef­fort to Su­per Bowl; Phar­ma ad­ver­tis­ers still spend big on TV

3 years ago
Pharma
Marketing

Vec­tor Bio­Med launch­es with $15M to pro­duce back­logged CAR-T com­po­nent

3 years ago
Financing
Startups

Q&A: No­vo Nordisk mar­ket­ing chief aims to change the con­ver­sa­tion around obe­si­ty, even as so­ci­ety has its own plans

3 years ago
Pharma
Marketing

Sen­so­ri­on part­ners on in­jec­tion sys­tem for ther­a­py de­liv­ery; Kymera and X-Chem ex­pand deal

3 years ago
News Briefing

No­var­tis' Xo­lair suc­ces­sor hit by an­oth­er PhI­II axe, but food al­ler­gy study con­tin­ues

3 years ago
R&D
Pharma

Gilead quash­es mi­cro­cap biotech's hope of part­ner­ing on oral Covid-19 drug

3 years ago
Deals

UniQure cash­es out $10M up­front to get can­di­date for in­her­it­ed ALS

3 years ago
Deals

Pfiz­er cuts eight pro­grams, in­clud­ing dwarfism drug at cen­ter of Ther­a­chon buy­out

3 years ago
R&D
First page Previous page 382383384385386387388 Next page Last page
A service from the Financial Times